Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The company's DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium. The company has collaboration agreements with Victorian Clinical Genetic Services; Vivlion GmbH.; Kyowa Kirin Pharmaceutical Research, Inc.; deepCDR Biologics AG; and Centogene N.V to develop advanced sequencing tools. It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets. Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco, California.

Twist Bioscience Corporation

Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. 

Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. 

Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise unavailable. Our technology overcomes inefficiencies and enables cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. We offer both the quality and quantity researchers need now to rapidly realize opportunities ahead. 

Twitter          @TwistBioscience
Facebook     facebook.com/TwistBioscience
YouTube       youtube.com/TwistBioscience

#WeMakeDNA

Capital World Investors

Kangmei Pharmaceutical

NFT Investment

Reinet Investments S.C.A.

Biomatics Capital Partners

Ditch Plains Capital Management LP

3W Partners

Bay City Capital

Dentsu Ventures

Asset Management Ventures (AMV)

E Squared Capital Management

Twist Bioscience

🧬 If you read one “look back” piece this time of year, this is certainly the one you should read. By Emily Leproust: A 10 Year Leap That Has Changed The World.

Twist Bioscience, #NGS, #DataStorage, #TwistBlog, #DNA

We have a treat for you! Aaron Sato’s talk from #ANTIBODYENG: “Writing the Future of Biologics with an Integrated Offering of Immunization, Libraries, & Machine Learning” including super interesting case studies. Check it out: https://lnkd.in/gHeGp9Ci

#antibody #antibodydiscovery #DNA #machinelearning

Don't miss this opportunity to accelerate your experiments with Twist Bioscience’s new Express Genes service! Unlock the door to limitless possibilities and propel your genetic research forward.

Order your Express Genes before capacity runs out: https://lnkd.in/gKR4i9fX

#gene #genes #DNA

Our miniaturization process allows us to write DNA more sustainably than traditional 96 well plate methods. A LOT more…

Learn more here: bit.ly/3QZzkjP

Twist Bioscience, #ESG, #DNA, #gene

Twisters across all sites have been gathering together to celebrate the holidays, end of year, and each other. Our South San Francisco, Wilsonville, and Carlsbad teams had a great time last week dressing up for a night out with snacks, drinks, friends and colleagues!

Wishing you a joyful holiday season and happy New Year! 🎁 🥂

COM:TWISTBIOSCIENCE

Twist Bioscience

Last Close

57.51

26/07 20:00

Market Cap

2.97B

Beta: -

Volume Today

666.23K

Avg: -